186 related articles for article (PubMed ID: 15837872)
21. Lentigo maligna successfully treated with imiquimod.
du Plessis PJ
S Afr J Surg; 2007 May; 45(2):72. PubMed ID: 17674567
[No Abstract] [Full Text] [Related]
22. Lentigo maligna managed with topical imiquimod and dermoscopy: report of two cases.
de Troya-Martín M; Frieyro-Elicegui M; Fúnez Liébana R; Aguilar Bernier M; Fernández-Canedo NI; Blázquez Sánchez N
Dermatol Surg; 2008 Nov; 34(11):1561-6. PubMed ID: 18798748
[No Abstract] [Full Text] [Related]
23. Usefulness of dermoscopy to monitor clinical efficacy of imiquimod treatment for lentigo maligna.
Micantonio T; Fargnoli MC; Peris K
Arch Dermatol; 2006 Apr; 142(4):530-1. PubMed ID: 16618884
[No Abstract] [Full Text] [Related]
24. [How I treat ... lentigo maligna by topical imiquimod].
Bourguignon R; Paquet P; Quatresooz P; Piérard GE
Rev Med Liege; 2005 Sep; 60(9):691-4. PubMed ID: 16265961
[TBL] [Abstract][Full Text] [Related]
25. Imiquimod: a novel treatment for lentigo maligna.
Ahmed I; Berth-Jones J
Br J Dermatol; 2000 Oct; 143(4):843-5. PubMed ID: 11069469
[TBL] [Abstract][Full Text] [Related]
26. Histologic resolution of melanoma in situ (lentigo maligna) with 5% imiquimod cream.
Chapman MS; Spencer SK; Brennick JB
Arch Dermatol; 2003 Jul; 139(7):943-4. PubMed ID: 12873902
[No Abstract] [Full Text] [Related]
27. Treatment of melanoma in situ on sun-damaged skin with topical 5% imiquimod cream complicated by the development of invasive disease.
Fisher GH; Lang PG
Arch Dermatol; 2003 Jul; 139(7):945-7. PubMed ID: 12873904
[No Abstract] [Full Text] [Related]
28. Extensive lentigo maligna clearing with topical imiquimod.
Epstein E
Arch Dermatol; 2003 Jul; 139(7):944-5. PubMed ID: 12873903
[No Abstract] [Full Text] [Related]
29. Image in clinical medicine. Lentigo maligna.
Noel B; Kunzle N
N Engl J Med; 2005 Nov; 353(20):2176. PubMed ID: 16291987
[No Abstract] [Full Text] [Related]
30. Management of lentigo maligna and lentigo maligna melanoma: seminars in surgical oncology.
Arlette JP; Trotter MJ; Trotter T; Temple CL
J Surg Oncol; 2004 Jul; 86(4):179-86. PubMed ID: 15221924
[TBL] [Abstract][Full Text] [Related]
31. Nature of inflammatory infiltrate in superficial cutaneous malignancies during topical imiquimod treatment.
Wolf IH; Kodama K; Cerroni L; Kerl H
Am J Dermatopathol; 2007 Jun; 29(3):237-41. PubMed ID: 17519620
[TBL] [Abstract][Full Text] [Related]
32. Imiquimod in the treatment of actinic keratoses and other intraepithelial neoplasms.
Flowers F
Int J Dermatol; 2002 May; 41 Suppl 1():12-5. PubMed ID: 12087813
[No Abstract] [Full Text] [Related]
33. Mapped serial excision for periocular lentigo maligna and lentigo maligna melanoma.
Malhotra R; Chen C; Huilgol SC; Hill DC; Selva D
Ophthalmology; 2003 Oct; 110(10):2011-8. PubMed ID: 14522781
[TBL] [Abstract][Full Text] [Related]
34. Cryosurgery during topical imiquimod: a successful combination modality for lentigo maligna.
Bassukas ID; Gamvroulia C; Zioga A; Nomikos K; Fotika C
Int J Dermatol; 2008 May; 47(5):519-21. PubMed ID: 18412875
[TBL] [Abstract][Full Text] [Related]
35. Surgical margins for lentigo maligna and lentigo maligna melanoma: the technique of mapped serial excision.
Huilgol SC; Selva D; Chen C; Hill DC; James CL; Gramp A; Malhotra R
Arch Dermatol; 2004 Sep; 140(9):1087-92. PubMed ID: 15381549
[TBL] [Abstract][Full Text] [Related]
36. Fractionated radiotherapy of lentigo maligna and lentigo maligna melanoma in 64 patients.
Schmid-Wendtner MH; Brunner B; Konz B; Kaudewitz P; Wendtner CM; Peter RU; Plewig G; Volkenandt M
J Am Acad Dermatol; 2000 Sep; 43(3):477-82. PubMed ID: 10954659
[TBL] [Abstract][Full Text] [Related]
37. Ocular effects of imiquimod with treatment of eyelid melanoma in situ.
Murchison AP; Washington CV; Soloman AR; Bernardino CR
Dermatol Surg; 2007 Sep; 33(9):1136-8. PubMed ID: 17760609
[No Abstract] [Full Text] [Related]
38. Staged excision for lentigo maligna and lentigo maligna melanoma: A retrospective analysis of 117 cases.
Hazan C; Dusza SW; Delgado R; Busam KJ; Halpern AC; Nehal KS
J Am Acad Dermatol; 2008 Jan; 58(1):142-8. PubMed ID: 18029055
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms underlying imiquimod-induced regression of basal cell carcinoma in vivo.
Urosevic M; Maier T; Benninghoff B; Slade H; Burg G; Dummer R
Arch Dermatol; 2003 Oct; 139(10):1325-32. PubMed ID: 14568837
[TBL] [Abstract][Full Text] [Related]
40. Viral and nonviral uses of imiquimod: a review.
Gupta AK; Cherman AM; Tyring SK
J Cutan Med Surg; 2004; 8(5):338-52. PubMed ID: 15868314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
